|
Current Drug Metabolism
ISSN: 1389-2002 - Volum 9, 10 Issues, 2008
Instructions for Authors
Manuscripts may be submitted openly to one of the following
Editors with a copy to Ms. S. Abbasi, Bentham
Science Publishers, P.O. Box 8484 R-101, Zoramin Residency,
Scheme 33, Gulzar-e-Hejri, Karachi - Pakistan; Fax Nos: +92-21-4612073,
+92-21-4975781, +92-21-4977491, +92-21-4819018, +92-21-4819019;
E-mail: sarwat@benthamscience.org,
without prior invitation at the following addresses:
Submissions from USA:
Chandra Prakash, Editor-in-Chief, Current
Drug Metabolism, Global Research and Development,
Pfizer, Inc., Eastern Point Road, Groton, CT 06340, USA; Tel:
+1-860-441-6415; Fax: +1-860-686-0654; E-mail:cdm2000@benthamscience.org
Caroline Lee, Associate Editor,
Pfizer Global Research and Development, 4245 Sorrento Valley
Blvd., San Diego, CA 92121-1408, USA; Tel: +1 619 622 5900;
Fax: +1 619 622 5999, E-mail: caroline.lee@Agouron.com
Thomayant Prueksaritanont, Associate
Editor, Merck Research Laboratories, Department of Drug
Metabolism, WP 75-100, West Point, PA 19486, USA; E-mail:
thomayant_prueksaritanont@merck.com
Kenneth A. Bachmann, Associate Editor,
Department of Pharmacology, College of Pharmacy, The University
of Toledo, Toledo, Ohio 43606, USA; Tel. Office: (419) 530-1912;
Fax: (419) 530-1909; E-mail: kbachma@utnet.utoledo.edu
Michael Sinz, Associate Editor,
Bristol Myers Squibb Pharmaceutical Research Institute, 5
Research Parkway, EF399, Wallingford, CT 06492, USA; Tel:
(203) 677-6646; Fax: (203) 677-6193; E-mail: michael.sinz@bms.com
Judy Bolton, Associate Editor; Department
of Medicinal Chemistry and Pharmacognosy (M/C 781), College
of Pharmacy, The University of Illinois at Chicago, 833 South
Wood St., Chicago, IL, 60612-7231, USA; Tel: (312) 996-5280
and (312) 906-9823; Fax: (312) 996-7107; E-mail: Judy.Bolton@UIC.edu
Urs A. Boelsterli, Associate Editor,
Boehringer Ingelheim Endowed Chair in Mechanistic Toxicology,
Professor of Toxicology, University of Connecticut, School
of Pharmacy, Department of Pharmaceutical Sciences, 69 North
Eagleville Road, Unit 3092, Storrs, CT 06269-3092, USA; Tel:
+1 (860) 486-4066 (secretariat); Fax: +1 (860) 486-5792; E-mail:
urs.boelsterli@uconn.edu
Submissions from Europe:
Amin Rostami-Hodjegan, Associate Editor,
Reader in Clinical Pharmacokinetics & Drug Metabolism,
Pharmacokinetics & Pharmacogenetics Group, Academic Unit
of Clinical Pharmacology, Division of Clinical Sciences (South),
University of Sheffield, Medicine & Pharmacology, The
Royal Hallamshire Hospital, Sheffield S10 2JF, UK; Tel: +44
114 2712156; Fax: +44 114 2261348; E-mail: a.rostami@sheffield.ac.uk
Hilde Spahn-Langguth, Associate Editor,
School of Pharmacy, Johannes Gutenberg-University, Staudingerweg
5, D-55099 Mainz, Germany; Tel: +20 2 7590713 or +49 171 5822758;
E-mails: spahnlan@uni-mainz.de,
Hilde.Spahn-Langguth@guc.edu.eg
Nico PE Vermeulen, Associate Editor,
LACDR-Section of Molecular Toxicology, Department of Chemistry
and Pharmacochemstry, Vrije Universiteit Amsterdam, De Boelelaan
1083, 1081 HV Amsterdam, The Netherlands; Tel: +31-20-4447590;
Fax: +31-20-4447610; E-mail: npe.vermeulen@few.vu.nl
Submissions from Asia:
Lee Jia, Associate Editor, National
Cancer Institute, NIH 6130 Executive Blvd, Rm 8042, Rockville,
MD, 20852-4907, USA; Phone: 301-435-9164; Fax: 301-480-4836;
E-mail: jiale@mail.nih.gov
Ken-ichi Fujita, Department of Clinical Oncology,
Saitama Medical University, 38 Morohongo, Moroyama-cho, Iruma-gun,
Saitama 350-0495, Japan; Tel/Fax: +81-49-276-2134; E-mail:
fujitak@saitama-med.ac.jp
For full review articles, the manuscript, written in English,
should not exceed 50 pages in length (ca. 30 printed pages)
and for mini-reviews a maximum of 40 pages in length (ca.
15 printed pages). The manuscript should be typed in double-spacing
throughout on A-4 or American quarto paper. Dot matrix print
or any print that is difficult to read is unacceptable. Two
copies of the manuscript must accompany the original (along
with a computer disk) and should be sent to the Editor-in-Chief
at his address. All pages should be numbered. Abbreviations
should be defined the first time they are used in the manuscript
and a list of abbreviations used should also be provided.
Manuscript Organization: The manuscript should be divided
as: Title page, abstract and the main text. The text may be
subdivided further according to the areas to be discussed.
This should be followed by the Acknowledgement (if any) and
Reference sections. The first page should contain the title,
the authors names (initials and surname only), with an asterisk
in front of the name of the principal author.
Conflict of Interest: Financial contributions
to the work being reported should be clearly acknowledged,
as should any potential conflict of interest.
Abstract: The abstract should not exceed 250 words
and it should condense the essential features of the review
article, with the focus on the major advances in the field.
Key Words: Authors must supply up to eight key words
along with their manuscript.
Text: The main text should begin on a separate page
and it may be subdivided into separate sections. The review
article should mention any previous important reviews in the
field and contain a comprehensive discussion starting with
the general background of the field. It should then go on
to discuss the salient features of recent developments. The
authors should avoid presenting material which has already
been published in a previous review. The reference numbers
should be given in square brackets in the text. Acknowledgements
should be kept to a minimum.
Tables: -
Data Tables should be submitted in Microsoft Excel or in Microsoft Word table
format.
- Each table should include
a title/caption explaining what the table shows. Detailed legends may then follow.
-
Tables should be given on separate pages with indications on the left hand margin
to the text, as to the appropriate placement of the tables.
-
Tables should not contain vertical rules.
-
Columns and rows of data should be made visibly distinct by ensuring the borders
of each cell display as black lines.
-
Tables should be numbered consecutively in order of their citation in the body
of the text, with Arabic numerals.
-
If a reference is cited in both the table and text, insert a lettered footnote
in the table to refer to the numbered reference in the text.
-
Tabular data provided as additional files can be submitted as an Excel spreadsheet.
Figures
/ Illustrations:
All authors must strictly follow the guidelines below for
preparing illustrations for publication in Current
Drug Metabolism.
Editorial
Requirements: The quality of the illustrations printed in the journal
largely depends on the quality of the figures/illustration provided by the author.
In preparing artwork or graphics for publication, keep in mind the following points.
- Submit the original artwork or a photographic
print of the original for publication.
- Do not submit photocopies (Hardcopy submission
requirement).
- Illustrations should be provided as separate
files, not embedded in the text. (Hardcopy submission requirement).
- Remove all color from graphics except for
those illustrations (Greyscale), which are intended to be
printed in color.
- Good quality of hardcopy originals is a requirement.
- Figures should be referred to as “Fig.
(1)”, “Fig. (2)” etc. in the
text with figure numbers in bold within round bracket.
- Revised manuscripts should contain a complete
set of artwork and photographs.
Technical
Details:
- Figures should be provided on high quality,
white, smooth opaque paper (Hardcopy requirement).
Format
& Resolution:
- The following file formats can be accepted
(Preference in order of appearance): TIFF, JPEG, GIF, PDF.
- Illustrations must fit a single or double
column format on the journal page, according to the following
guideline below:
|
HEIGHT | WIDTH |
SINGLE COLUMN |
24 cm (max) |
8.5 cm (max) | DOUBLE
COLUMN | 24
cm (max) | 18
cm (max) |
- Whenever possible, submit graphics that do
not have to be reduced to fit the standard figure size or
alternatively, submit the figures in their original program
in which they have been drawn.
- Use the best resolution available (hardcopy
submission requirement). For online submission the maximum
resolution is 300 dpi.
- Avoid textures and shadings giving a three-dimensional
effect to the illustration.
- Symbols and lettering in the illustration
should be of similar size.
- Smaller lettering is used.
- Font: Times New Roman or Helvetica is preferable.
Font size: 10pt (maximum).
- Line drawings should have clear and sharp
lines and should be of uniform density. Moreover, lines
should be continuous without any breaks.
- Do not use lines thinner than 1 point.
Color Figures / Illustrations:
Photographs: Submit
high-contrast prints that are of single- or double-column width so that they will
not have to be reduced when printed. Negatives are not acceptable. However, in
case of hardcopy submission, color illustrations and plates can be published from
35 mm color slides. Chemical Structures: Chemical structures must
be prepared according to the guidelines below. Structures should be prepared
using a suitable drawing program e.g. ChemDraw and provided as separate file,
submitted both on disk and in printed formats.
Numbers in bold should identify all chemical structure. If
a name is also used to describe the compound, the associated
number in bold should be in parenthesis, e.g. “compound
(1)”.
Structure
Drawing Preferences: [As according to the ACS style sheet] Drawing
Settings:
Chain angle 120°
Bond spacing 18% of width Fixed length 14.4
pt (0.500cm, 0.2in) Bold width
2.0 pt (0.071cm, 0.0278in) Line width
0.6 pt (0.021cm, 0.0084in) Margin width
1.6 pt (0.096cm) Harsh spacing 2.5 pt (0.088cm, 0.0347in)
Text Settings:
Font Times
New Roman / Helvetica
Size 8pt
Under
the Preference Choose: Units
points Tolerances 3
pixels Under Page Setup Use: Paper US
letter Scale
100%
References: All references
must be numbered in the text in square brackets, e.g. [4],
or [7,10-15], in order of citation in the text. Titles of
journals are abbreviated according to Chemical Abstract Service
Source Index, example:
[1] Gibbs, M.A.; Thummel, K.E.; Shen, D.D. and Kunze, K.L.
(1999) Drug Metab. Dispos., 27(2), 180-187.
[2] Meyer, M.C.; Straughn, A.B.; Mhatre, R.M.; Shah, V.P.;
Williams, R.L. and Lesko L.J. (1998) Pharm. Res., 15(11),
1787-1791.
[3] Working, P.K. (1992) in Protein Pharmacokinetics and
Metabolism, (Ferraiolo, B.L.; Mohler, M.A. and Gloff,
C.A. Eds.), Plenum Press, New York, pp. 73-92.
Abstracts, unpublished data and personal communications (which
can only be included if the permission has been obtained)
should not be given in the reference section but they may
be mentioned in the text with details provided as footnotes.
All authors of referenced papers must be cited and there must
be no use of the short hand version of et al. when
citing the authors.
Page Charges: No page charges will be levied to authors.
Manuscript Submission: Two copies of the final manuscript
must accompany the original along with the soft copy of the
manuscript on a computer floppy disk(s) in MS Word file format
(or created in any other well-known word processing software)
should be submitted. To achieve rapid publication authors
are encouraged to e-mail or fax their submission to the appropriate
editorial office (see above) at the same time that they mail
the manuscript. For even faster publication, authors are encouraged
to submit their entire manuscript via Bentham Science's online
submission service (see below). Authors must provide their
full address, telephone and Fax numbers with E-Mail address
with all submissions.
For expedient and speedy reviewing of author's manuscripts,
authors are strongly advised to include the PDF file of their
manuscript on a floppy or zip disk, into the mailing material.
At the same time the package is mailed, please also send by
e-mail a copy of the PDF and MS Word files of the manuscript
to the editorial office.
Online Manuscript Submission: (preferable)
To facilitate speedy and cost-effective submission of abstracts
and manuscripts, an online submission and tracking service
via Internet is being offered. Once the Editor-in-Chief of
the journal has accepted your abstract, we would prefer that
you submit your full manuscript online via our online submission
service available at www.bentham-mps.org
or by FTP submission at www.bentham-ftp.org
For online submission, please provide your complete manuscript
in the form of a single zipped folder containing
all the material (main text, figures/ illustrations, tables,
chemical structures drawn in ChemDraw) as separate
files and a PDF version of the entire manuscript
with all the figures/ illustrations, tables, chemical structures,
etc., embedded in the text in the appropriate place. Authors
are required to proofread the PDF version of their manuscript
before submission. The article will be published exactly
as received and the Publishers will not be responsible for
any error occurring in the manuscript in this regard.
You may, however, still submit your abstracts and manuscripts
through conventional surface mail.
A successful electronic submission of a manuscript will be
followed by a system-generated acknowledgement to the principal/corresponding
author within 72 hours of the dispatch of
the manuscript. Any queries therein should be addressed to
mahmood@bentham.org
and copied to Jalil@bentham.org
Page Charges: No page charges will be levied to authors.
Language Editing: Manuscripts submitted containing
many English typographical errors will not be published. Authors
from non-English language countries are advised to use the
services of our professional language editing department prior
to submitting their manuscript to the Journal. Please contact
Bentham Publishing Services www.benthampublishingservices.com
for a language editing quote at e-mail: info@benthampublishingservices.com
stating the total number of words of the article to be edited.
Proofs: Authors are sent page proofs. To
avoid delays in publication, proofs should be checked immediately
for typographical errors and returned within 48 hours. Authors
will be charged for excessive changes made at the page proof
stage.
Reprints: Each first named author will receive
by e-mail a free copy of their article as a PDF file. The
PDF file is a watermarked version of the published article
which is exclusively for the author's own use and may not
be copied or distributed. Reprints may be ordered from the
Publisher prior to publication of the article. First named
authors may also order a personal print and online subscription
of the journal at 50% off the normal subscription rate by
contacting the subscription department at e-mail: subscriptions@bentham.org
Bentham Open Access: Accepted articles can
be published online for free open access for all to view.
Open access publishing provides the maximum dissemination
of the article to the largest audience. Authors must pay for
this service. All corresponding authors will be asked to indicate
whether or not they wish to pay to have their paper made freely
available on publication. If authors do not select the Open
Access option, then their article will be published with standard
subscription-based access at no charge. Open access articles
are published under the terms of the Creative Commons Attribution
Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)
which permits unrestricted, non-commercial use, distribution
and reproduction in any medium, provide the work is properly
cited.
Bentham Science offers authors the choice of open access publication
of their articles at a fee of US$ 1,500 per published article
which allows indefinite online publication with BOTH Bentham
Science, PubMed Central and UK PubMed Central. For more information
please contact us at e-mail: openaccess@bentham.org
Reviewing and Promptness of Publication:
All papers submitted for publication will be immediately subjected
to editorial scrutiny, usually in consultation with members
of the Editorial Board. Every effort will be made to assess
the papers quickly and the decision conveyed to the authors
normally within two weeks of the receipt of the paper. The
papers will be typeset and the proofs despatched to the authors
normally within 4 weeks of their acceptance. Please provide
your telephone and Fax numbers with your E-Mail address with
all submissions.
Copyright: It is a condition of publication
that manuscripts submitted to this journal have not been published
and will not be simultaneously submitted or published elsewhere.
Plagiarism is strictly forbidden, and by submitting the article
for publication the authors agree that the publishers have
the legal right to take appropriate action against the authors,
if plagiarism is discovered. By submitting a manuscript the
authors agree that the copyright of their article is transferred
to the publishers if and when the article is accepted for
publication.
|
